Low-dose hormone therapy for postmenopausal women

被引：6

作者：

Archer, DF ^{[1
]}

机构：

[1] Eastern Virginia Med Sch, Jones Inst Reprod Med, Dept Obstet & Gynecol, Norfolk, VA 23507 USA

来源：

CLINICAL OBSTETRICS AND GYNECOLOGY | 2003年 / 46卷 / 02期

关键词：

D O I：

10.1097/00003081-200306000-00010

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

[No abstract available]

引用

页码：317 / 324

页数：8

共 41 条

[1] Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate [J].

Archer, DF ;

Dorin, MH ;

Heine, W ;

Nanavati, N ;

Arce, JC .

OBSTETRICS AND GYNECOLOGY, 1999, 94 (03) :323-329

[2] Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding [J].

Archer, DF ;

Dorin, M ;

Lewis, V ;

Schneider, DL ;

Pickar, JH .

FERTILITY AND STERILITY, 2001, 75 (06) :1080-1087

[3] The assessment of bleeding patterns in postmenopausal women during continuous combined hormone replacement therapy: a review of methodology and recommendations for reporting of the data [J].

Archer, DF ;

Pickar, JH .

CLIMACTERIC, 2002, 5 (01) :45-59

[4] The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women [J].

Archer, DF .

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2001, 8 (04) :245-251

[5]

Baerug U, 1998, Climacteric, V1, P219

[6] Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women [J].

Davidson, MH ;

Maki, KC ;

Marx, P ;

Maki, AC ;

Cyrowski, MS ;

Nanavati, N ;

Arce, JC .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (21) :3315-3325

[7] A combination of low doses of 17β-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women [J].

Delmas, PD ;

Confavreux, E ;

Garnero, P ;

Fardellone, P ;

de Vernejoul, MC ;

Cormier, C ;

Arce, JC .

OSTEOPOROSIS INTERNATIONAL, 2000, 11 (02) :177-187

[8] LOW-DOSAGE MICRONIZED 17-BETA-ESTRADIOL PREVENTS RONE LOSS IN POSTMENOPAUSAL WOMEN [J].

ETTINGER, B ;

GENANT, HK ;

STEIGER, P ;

MADVIG, P .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (02) :479-488

[9] Cardiovascular disease outcomes during 6.8 years of hormone therapy - Heart and Estrogen/progestin Replacement Study follow-up (HERS II) [J].

Grady, D ;

Herrington, D ;

Bittner, V ;

Blumenthal, R ;

Davidson, M ;

Hlatky, M ;

Hsia, J ;

Hulley, S ;

Herd, A ;

Khan, S ;

Newby, LK ;

Waters, D ;

Vittinghoff, E ;

Wenger, N .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (01) :49-57

[10] Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women [J].

Grodstein, F ;

Stampfer, MJ ;

Falkeborn, M ;

Naessen, T ;

Persson, I .

EPIDEMIOLOGY, 1999, 10 (05) :476-480

← 1 2 3 4 5 →